Cargando…
Effect of rapamycin on bone mass and strength in the α2(I)‐G610C mouse model of osteogenesis imperfecta
Osteogenesis imperfecta (OI) is commonly caused by heterozygous type I collagen structural mutations that disturb triple helix folding and integrity. This mutant‐containing misfolded collagen accumulates in the endoplasmic reticulum (ER) and induces a form of ER stress associated with negative effec...
Autores principales: | Bateman, John F., Sampurno, Lisa, Maurizi, Antonio, Lamandé, Shireen R., Sims, Natalie A., Cheng, Tegan L., Schindeler, Aaron, Little, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378195/ https://www.ncbi.nlm.nih.gov/pubmed/30597759 http://dx.doi.org/10.1111/jcmm.14072 |
Ejemplares similares
-
The effect of carbamazepine on bone structure and strength in control and osteogenesis imperfecta (Col1a2 (+/p.G610C)
) mice
por: Blank, Martha, et al.
Publicado: (2022) -
Morphological and mechanical characterization of bone phenotypes in the Amish G610C murine model of osteogenesis imperfecta
por: Kohler, Rachel, et al.
Publicado: (2021) -
Curative Cell and Gene Therapy for Osteogenesis Imperfecta
por: Schindeler, Aaron, et al.
Publicado: (2022) -
Induction of periosteal bone formation by intraosseous BMP-2 injection in a mouse model of osteogenesis imperfecta
por: Cheng, T. L., et al.
Publicado: (2019) -
Osteogenesis imperfecta
por: Vitturi, Bruno Kusznir, et al.
Publicado: (2018)